Wow!! De novo design of drug-binding proteins with predictable binding energy and specificity | Science science.org/doi/10.1126/sc…

Jacob Hooker: Could HDAC6i be the next GLP-1 agonist? linkedin.com/posts/jacob-ho…

Nature research paper: Bitter taste receptor activation by cholesterol and an intracellular tastant go.nature.com/3U7ZW3v

Impact of Repeated Blast Exposure in Active-Duty U.S. Special Operations Forces: pnas.org/doi/10.1073/pn… We thank the 30 SOF participants, who bring the military one step closer to a diagnostic test for repeated blast brain injury. MGH Neurology MGH Martinos Center MGH Center for Neurotechnology and Neurorecovery

Multidisciplinary team at MGH Martinos Center MGH Center for Neurotechnology and Neurorecovery studied 30 active-duty U.S. Special Operations Forces: pnas.org/doi/10.1073/pn… Increased blast exposure was associated with structural, functional and neuroimmune changes in the brain detected by MRI & PET: massgeneral.org/news/press-rel…

Really excited to share the hard work of a killer team. This project was a long time in the making and hit the COVID shutdown timeline and “penalty” but the team saw it through and it’s really great science. ACS Central Science pubs.acs.org/doi/10.1021/ac…

Neuroimaging, blood proteomics, and health data from 30 military personnel show that increased exposure to explosive blasts was associated with structural and functional brain alterations and a decrease in health-related quality of life. In PNAS: ow.ly/bfNA50RpWfO

An orangutan in Sumatra surprised scientists when he was seen treating an open wound on his cheek with a poultice made from a medicinal plant go.nature.com/3UrXtjk

Whoo hoo! Major paper now out in Science, Space & Robots : "AlphaFold2 structures guide prospective ligand discovery" Collaboration with Bryan Roth Brian Shoichet Skiniotis, Kruse, Enamine Ltd 🇺🇦

Today the world can watch a film that has been called “the best movie I have seen in 30 years.” For Love & Life: No Ordinary Campaign is now streaming on Prime Video. After you watch the documentary, please review it on the Amazon page for the film. amazon.com/gp/video/detai…

📢New collection of #ACSChemNeuro research as the FDA is expected to announce a decision on a new treatment involving #MDMA today ⏰ Read the latest research ➡ go.acs.org/9Er

Fascinating discussions online today surrounding the FDA's consideration of a new #MDMA treatment for PTSD 🤔 When is a double-blinded study not enough? How can you blind for a treatment that includes such pronounced and well-known effects? Let us know what you think! ⬇

FDA Advisory Committee votes against recommending Lykos' #MDMA treatment for PTSD Read our latest MDMA research here ➡ go.acs.org/9Er

ACSChemNeurosci BryanRoth Super interesting discussion about expectancy bias… check out pubs.acs.org/doi/10.1021/ac…

Overall, I thought the discussion was less focused on the tremendous unmet need. Maybe I’m a bit too cavalier, but I certainly felt the benefits outweigh the risks (with plenty of guardrail caveats).

And that's a wrap on #BIO2024! Our CEO, Rick Lundberg, spent a busy few days meeting with #biotech & #pharma industry partners and investors while still making time to enjoy some of the sights in beautiful San Diego.

📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/9Mn

Wow. The Harris team are out of the blocks in lightening quick time with this superb ad

Eikonizo Therapeutics is excited to be in Philly for the Alzheimer's Association #AAIC24. A great opportunity to learn from and meet with some of the best and brightest in dementia research. If you see our CEO Rick Lundberg, be sure to stop and say hello!

Our latest paper describes automated synthesis and preclinical imaging of a novel [18F]Fluorolidocaine analog via sequential C-H radiolabeling and is out in RSC Medicinal Chemistry. Congrats Madison Frazier (she/her) (1st paper!) Jay Wright Allen Brooks. Read it here: pubs.rsc.org/en/Content/Art…